Evidence map›Paper›PMID 33786655›Full record

ArticleEuropean radiology2021

Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.

Liang Li, Li Wang, Feifei Zeng, Gongling Peng, Zan Ke, Huan Liu, Yunfei Zha

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. CT-based radiomics nomogram for distinguishingTranslational pediatrics · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Liang Li *Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Li Wang *Department of Infection Prevention and Control, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Feifei ZengDepartment of Radiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Gongling PengDepartment of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Zan KeDepartment of Radiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Huan LiuGE Healthcare, Shanghai, 201203, China.
Yunfei ZhaDepartment of Radiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. zhayunfei999@126.com.ORCID http://orcid.org/0000-0002-8714-7472
Wuhan University · CNCentral Hospital of Wuhan · CNUnited Imaging Healthcare (China) · CN

Funding

Novel Coronavirus Pneumonia Emergency Key Project of Science and Technology of Hubei Province 2020FCA015the Fundamental Research Funds for the Central Universities 2042020kfxg10the National Natural Science Foundation of China 81601461the National Natural Science Foundation of China 81871332
6 · The paper itself

Abstract

objectivesTo develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND

methodsThree hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness.

resultsSixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843-0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796-0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761-0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708-0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703-0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581-0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone.

conclusionsThe CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy. KEY POINTS: • Radiomics can be applied in CT images of COVID-19 and radiomics signature was an independent predictor of severe COVID-19. • CT-based radiomics model can predict severe COVID-19 with satisfactory accuracy compared with subjective CT findings and clinical factors. • Radiomics nomogram integrated with the radiomics signature, subjective CT findings, and clinical factors can achieve better severity prediction with improved diagnostic performance.

Indexed as

COVID-19HumansNomogramsRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedCOVID-19NomogramsPneumoniaTomography, X-ray computed

Identifiers

PMID33786655
PMCPMC8009273
OpenAlexW3152023345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.